ASRS 2019 Street Team: Raj K. Maturi, MD

Article
Conference|ASRS

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

Raj K. Maturi, MD, discusses phase II data from the abicipar Phase II MAPLE Trial for patients with AMD at the 2019 annual ASRS conference.

Recent Videos
Marion Munk, MD, PhD, presenting slides
Marion Munk, MD, PhD, presenting slides
Related Content
4DMT announces the publication of preclinical data in Investigative Ophthalmology & Visual Science

4DMT announces the publication of preclinical data in Investigative Ophthalmology & Visual Science

Sydney M Crago
December 20th 2024
Article
Putting in practice retina innovations amid a pandemic

Putting in practice retina innovations amid a pandemic

Alex Delaney-Gesing
August 28th 2020
Podcast
AMD-HALT program receives Eurostars grant for continued investigation of dry AMD gene therapy platform

AMD-HALT program receives Eurostars grant for continued investigation of dry AMD gene therapy platform

Hattie Hayes
December 16th 2024
Article
EyePod

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

Alex Delaney-Gesing
July 29th 2020
Podcast
Outlook Therapeutics reveals preliminary topline results of NORSE EIGHT

Outlook Therapeutics reveals preliminary topline results of NORSE EIGHT

Sydney M Crago
December 6th 2024
Article
Galimedix Therapeutics initiates Phase 1 trial of oral GAL-101

Galimedix Therapeutics initiates Phase 1 trial of oral GAL-101

David Hutton
December 6th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.